1. Home
  2. KNSL vs PODD Comparison

KNSL vs PODD Comparison

Compare KNSL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

N/A

Current Price

$399.36

Market Cap

8.9B

Sector

Finance

ML Signal

N/A

Logo Insulet Corporation

PODD

Insulet Corporation

N/A

Current Price

$133.84

Market Cap

10.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KNSL
PODD
Founded
2009
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
10.2B
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
KNSL
PODD
Price
$399.36
$133.84
Analyst Decision
Hold
Buy
Analyst Count
12
26
Target Price
★ $354.56
$177.91
AVG Volume (30 Days)
244.4K
★ 1.2M
Earning Date
10-22-2026
11-04-2026
Dividend Yield
★ 0.25%
N/A
EPS Growth
★ 21.77
N/A
EPS
★ 16.97
4.69
Revenue
$1,873,987,000.00
★ $2,708,100,000.00
Revenue This Year
$3.76
$22.02
Revenue Next Year
N/A
$11.70
P/E Ratio
★ $23.31
$29.27
Revenue Growth
18.04
★ 30.73
52 Week Low
$287.20
$126.40
52 Week High
$421.90
$342.13

Technical Indicators

Market Signals
Indicator
KNSL
PODD
Relative Strength Index (RSI) 61.15 36.46
Support Level $349.06 $128.80
Resistance Level $405.41 $150.04
Average True Range (ATR) 10.80 8.12
MACD 0.01 -2.36
Stochastic Oscillator 77.88 2.78

Price Performance

Historical Comparison
KNSL
PODD

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: